These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24094709)

  • 21. Molecular imaging of inflammation in inflammatory bowel disease with a clinically translatable dual-selectin-targeted US contrast agent: comparison with FDG PET/CT in a mouse model.
    Wang H; Machtaler S; Bettinger T; Lutz AM; Luong R; Bussat P; Gambhir SS; Tranquart F; Tian L; Willmann JK
    Radiology; 2013 Jun; 267(3):818-29. PubMed ID: 23371306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18F-FDG-PET/CT in fever of unknown origin: clinical value.
    Buch-Olsen KM; Andersen RV; Hess S; Braad PE; Schifter S
    Nucl Med Commun; 2014 Sep; 35(9):955-60. PubMed ID: 24801131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diuretic 18F-Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Genitourinary Malignancies.
    Agarwal KK; Roy SG; Kumar R
    PET Clin; 2016 Jan; 11(1):39-46. PubMed ID: 26590442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimal invasive biopsy of intraconal expansion by PET/CT/MRI image-guided navigation: a new method.
    Reinbacher KE; Pau M; Wallner J; Zemann W; Klein A; Gstettner C; Aigner RM; Feichtinger M
    J Craniomaxillofac Surg; 2014 Oct; 42(7):1184-9. PubMed ID: 24726395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the utility of whole-body MRI with and without contrast-enhanced Quick 3D and double RF fat suppression techniques, conventional whole-body MRI, PET/CT and conventional examination for assessment of recurrence in NSCLC patients.
    Ohno Y; Nishio M; Koyama H; Yoshikawa T; Matsumoto S; Takenaka D; Seki S; Tsubakimoto M; Sugimura K
    Eur J Radiol; 2013 Nov; 82(11):2018-27. PubMed ID: 24012452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High diagnostic value of 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease.
    Löffler M; Weckesser M; Franzius C; Schober O; Zimmer KP
    Ann N Y Acad Sci; 2006 Aug; 1072():379-85. PubMed ID: 17057218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Special Techniques in PET/Computed Tomography Imaging for Evaluation of Head and Neck Cancer.
    Kumar R; Mukherjee A; Mittal BR
    PET Clin; 2016 Jan; 11(1):13-20. PubMed ID: 26590440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Beware of PET-CT results in cases of cancer occurring in the setting of chronic inflammatory bowel disease].
    Bonaventure T; Goéré D; Boige V; Pocard M
    J Chir (Paris); 2009 Dec; 146(6):579-82. PubMed ID: 19906376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abdomen: normal variations and benign conditions resulting in uptake on FDG-PET/CT.
    Zukotynski K; Kim CK
    PET Clin; 2014 Apr; 9(2):169-83. PubMed ID: 25030280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Imaging in Inflammatory Bowel Disease.
    Noriega-Álvarez E; Martín-Comín J
    Semin Nucl Med; 2023 Mar; 53(2):273-286. PubMed ID: 36702729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review.
    Treglia G; Annunziata S; Sobic-Saranovic D; Bertagna F; Caldarella C; Giovanella L
    Acad Radiol; 2014 May; 21(5):675-84. PubMed ID: 24703482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (18)F-FDG PET/CT imaging in granulomatosis with polyangiitis.
    De Geeter F; Gykiere P
    Hell J Nucl Med; 2016; 19(1):5-6. PubMed ID: 26929934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACR-ASNR Practice Parameter for Brain PET/CT Imaging Dementia.
    Frey KA; Lodge MA; Meltzer CC; Peller PJ; Wong TZ; Hess CP; Petrella JR; Sair HI; Subramaniam RM
    Clin Nucl Med; 2016 Feb; 41(2):118-25. PubMed ID: 26646994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune reconstitution inflammatory syndrome due to Mycobacterium avium complex successfully followed up using 18 F-fluorodeoxyglucose positron emission tomography-computed tomography in a patient with human immunodeficiency virus infection: A case report.
    Namkoong H; Fujiwara H; Ishii M; Yagi K; Haraguchi M; Matsusaka M; Suzuki S; Asakura T; Asami T; Saito F; Fukunaga K; Tasaka S; Betsuyaku T; Hasegawa N
    BMC Med Imaging; 2015 Jul; 15():24. PubMed ID: 26187282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FDG PET and PET/CT.
    Krause BJ; Schwarzenböck S; Souvatzoglou M
    Recent Results Cancer Res; 2013; 187():351-69. PubMed ID: 23179888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up.
    Quartuccio N; Fox J; Kuk D; Wexler LH; Baldari S; Cistaro A; Schöder H
    AJR Am J Roentgenol; 2015 Jan; 204(1):153-60. PubMed ID: 25539251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.